Sivik Global Healthcare’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sivik Global Healthcare’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,500	Closed	-$1.91M	–	56
2016 Q2	$1.91M	Buy	+13,500	New	+$1.99M	0.95%	48
2015 Q4	–	Sell	-4,800	Closed	-$637K	–	64
2015 Q3	$637K	Sell	4,800 -12,500	-72%	-$2.15M	0.31%	56
2015 Q2	$3.05M	Sell	17,300 -5,200	-23%	-$934K	1.06%	38
2015 Q1	$3.89M	Buy	22,500 +2,700	+14%	+$463K	1.32%	32
2014 Q4	$3.24M	Sell	19,800 -5,200	-21%	-$863K	1.31%	35
2014 Q3	$4.01M	Buy	25,000 +8,100	+48%	+$1.25M	1.82%	21
2014 Q2	$2.48M	Buy	+16,900	New	+$2.34M	1.25%	37

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sivik Global Healthcare's JAZZ Position: Q3 2016 in Review

Sivik Global Healthcare sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 13,500 shares — an estimated $1.91M sold.

Sivik Global Healthcare first reported a position in JAZZ in Q2 2014 and held it in 7 quarters. The position peaked at $4.01M in Q3 2014. 326 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Sivik Global Healthcare reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Sivik Global Healthcare sold 13,500 Jazz Pharmaceuticals shares in Q3 2016, an estimated $1.91M.
Sivik Global Healthcare first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 7 quarters.
Sivik Global Healthcare's Jazz Pharmaceuticals position peaked at $4.01M in Q3 2014.
326 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Sivik Global Healthcare's 13F filing for Q3 2016, filed 14 Nov 2016.